Expert Opinion on Investigational Drugs

New antiangiogenic strategies for the treatment of proliferative synovitis
pp. 1-17(17)
Authors: Dahlia T Lainer; Ernest Brahn

Drugs to suppress cough
pp. 19-27(9)
Author: K F Chung

Recent advances in the treatment of non-alcoholic fatty liver disease
pp. 29-35(7)
Authors: Flavia D Mendes; Keith D Lindor

Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis?
pp. 37-44(8)
Authors: Varun Kapila; Frank W Sellke; Erik J Suuronen; Thierry G Mesana; Marc Ruel

Thalidomide and immunomodulatory drugs in the treatment of cancer
pp. 45-55(11)
Authors: Aristotle Bamias; Meletios A Dimopoulos

Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs
pp. 57-64(8)
Author: Rolf Mentlein

Rheumatoid disease and the heart: from epidemiology to echocardiography
pp. 65-76(12)
Authors: Gurbir S Bhatia; Michael D Sosin; Karl A Grindulis; Russell C Davis; Gregory YH Lip

Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease
pp. 77-88(12)
Author: Mario H Cardiel

BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia
pp. 89-91(3)
Author: Sheila A Doggrell

44th Interscience Conference on Antimicrobial Agents and Chemotherapy: an update on new antibiotics, novel non-antibacterial treatment modalities and critical issues in antibiotic resistance
pp. 93-99(7)
Author: Michael N Alekshun